Heterodimerization with 5-HT2BR Is Indispensable for β2AR-mediated Cardioprotection
Ying Song Chanjuan Xu Jianfeng Liu Yulong Li Huan Wang Dan Shan Irving W Wainer Xinli Hu Yan Zhang Anthony Yiu-Ho Woo Rui-Ping Xiao Institute of Molecular Medicine,Peking University,CHINA Sino-France Laboratory of Cellular Signaling,Huazhong University of Science and Technology Sino-France Laboratory of Cellular Signaling,Huazhong University of Science and Technology,CHINA School of Life Sciences,Peking University,CHINA PAZ Pharmaceuticals Pharmacology,Shenyang Pharmaceutical University,CHINA College of Life Sciences and Institute of Molecular Medicine,Peking University,CHINA
DOI: https://doi.org/10.1161/circresaha.120.317011
IF: 23.213
2020-11-19
Circulation Research
Abstract:Rationale: The β 2 -adrenoceptor (β 2 -AR), a prototypical G protein-coupled receptor (GPCR), couples to both G s and G i proteins. Stimulation of theβ 2 -AR is beneficial to humans and animals with heart failure presumably because it activates the downstream G i -PI3K-Akt cell survival pathway. Cardiac β 2 -AR signaling can be regulated by crosstalk or heterodimerization with other GPCRs, but the physiological and pathophysiological significance of this type of regulation has not been sufficiently demonstrated. Objective: Here, we aim to investigate the potential cardioprotective effect of β 2 -adrenergic stimulation with a subtype-selective agonist, (R,R')-4-methoxy-1-naphthylfenoterol (MNF), and to decipher the underlying mechanism with a particular emphasis on the role of heterodimerization of β 2 -ARs with another GPCR, 5-hydroxytryptamine receptors 2B (5-HT 2B Rs). Methods and Results: Using pharmacological, genetic and biophysical protein-protein interaction approaches, we studied the cardioprotective effect of the β 2 -agonist, MNF, and explored the underlying mechanism in both in vivo in mice and cultured rodent cardiomyocytes insulted with doxorubicin (Dox), hydrogen peroxide (H 2 O 2 ) or ischemia/reperfusion. In Dox-treated mice, MNF reduced mortality and body weight loss, while improving cardiac function and cardiomyocyte viability. MNF also alleviated myocardial ischemia/reperfusion injury. In cultured rodent cardiomyocytes, MNF inhibited DNA damage and cell death caused by Dox, H 2 O 2 or hypoxia/reoxygenation. Mechanistically, we found that MNF or another β 2 -agonist zinterol markedly promoted heterodimerization of β 2 -ARs with 5-HT 2B Rs. Upregulation of the heterodimerized 5-HT 2B Rs and β 2 -ARs enhanced β 2 -AR-stimulated Gi-Akt signaling and cardioprotection while knockdown or pharmacological inhibition of the 5-HTattenuated β 2 -AR-stimulated G i signaling and cardioprotection. Conclusions: These data demonstrate that the β 2 -AR-stimulated cardioprotective Gi signaling depends on the heterodimerization of β 2 -ARs and 5-HT 2B Rs.
cardiac & cardiovascular systems,peripheral vascular disease,hematology